The results provided a novel insight into the portion of mechanism underlying BMI1-mediated chemoresistance in bladder cancer, presenting BMI1 as a valuable prognosis indicator and potential therapeutic target for GC-resistant bladder cancer. The gene discussed is BMI1; the disease is urinary bladder carcinoma.